Journal
JOURNAL OF MATERIALS CHEMISTRY
Volume 22, Issue 39, Pages 21305-21312Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c2jm33482h
Keywords
-
Funding
- Region Wallonne through the TARGAN project
- FRS-FNRS, (FRFC) [2.4.550.09, 2.4.617.07.F, F.4.505.10.F]
- Associazione Italiana Ricerca sul Cancro (AIRC)
- Loterie Nationale
- ARC project [09/14-023]
- University of Namur
- FRS-FNRS
Ask authors/readers for more resources
Gold nanoparticles (similar to 5 nm) coated with plasma-polymerized allylamine were produced through plasma vapor deposition and bioconjugated with a monoclonal antibody targeting the epidermal growth factor receptor. The resulting nanoconjugates displayed an antibody loading of about 1.7 nmol mg(-1) and efficiently target epidermal growth factor receptor overexpressing cell lines, as ascertained by ELISA and Western blot assays. The in vitro targeting properties were also confirmed in vivo, where a similar biodistribution profile of what was experienced for the unconjugated antibody was observed. Thanks to the possibility of doping the gold nanoparticles with radionuclides during plasma vapor deposition, the proposed functionalization strategy represents a very suitable platform for the in vivo cancer targeting with nanosized multifunctional particles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available